Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03193658Not ApplicableCompleted

USG Thoracolumbar Interfascial Plane (TLIP) in Lumbar Spine Surgeries

Role: lead

NCT03193723Not ApplicableCompleted

Ultrasound Guided Local Anesthetic Field Block (A Five Step Procedure) for Open Inguinal Hernia Repair

Role: lead

NCT03193632Completed

Predicting Resting Energy Expenditure in Critically Ill Patients by Measuring Lean Body Mass by US

Role: lead

NCT03042663Not ApplicableUnknown

Effect of Stellate Ganglion Block on Blood Flow in the Cannulated Radial Artery

Role: lead

NCT03043495Phase 4Unknown

Dexamethasone Dose in Low Volume Bupivacaine USG Supraclavicular Block

Role: lead

All 5 trials loaded